{"entity":{"type":"insider","cik":"0001738081","url":"/insider/0001738081","json_url":"/insider/0001738081.json","name":"Mostafa Adam S.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":21,"first":"2020-07-01","last":"2025-01-27","span_basis":"filed_date"},"name_variants":[{"name":"Mostafa Adam S.","source":"filing","n_filings":21,"first_seen":"2020-07-01","last_seen":"2025-01-27"}],"transactions":[{"id":4600953,"accession":"0001628280-25-002708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-002708","line_url":"/filing/0001628280-25-002708#line-2","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74773.0,"shares_display":"74,773","price_per_share":0.454,"price_display":"0.45","price_state":"stated","total_value":33946.942,"total_display":"33,946.94","total_whole":"33,947","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-24","filed_date":"2025-01-27","scope":"insider"},{"id":2260272,"accession":"0001628280-24-042545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-042545","line_url":"/filing/0001628280-24-042545#line-2","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230645.0,"shares_display":"230,645","price_per_share":0.5502,"price_display":"0.55","price_state":"stated","total_value":126900.879,"total_display":"126,900.88","total_whole":"126,901","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-07","filed_date":"2024-10-08","scope":"insider"},{"id":2647555,"accession":"0001628280-24-010279","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-010279","line_url":"/filing/0001628280-24-010279#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52500.0,"shares_display":"52,500","price_per_share":0.8828,"price_display":"0.88","price_state":"stated","total_value":46347.0,"total_display":"46,347.00","total_whole":"46,347","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-11","scope":"insider"},{"id":3135523,"accession":"0001628280-24-004263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-004263","line_url":"/filing/0001628280-24-004263#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27721.0,"shares_display":"27,721","price_per_share":1.0091,"price_display":"1.01","price_state":"stated","total_value":27973.2611,"total_display":"27,973.26","total_whole":"27,973","shares_owned_after":52500.0,"shares_owned_after_display":"52,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-12","scope":"insider"},{"id":8617181,"accession":"0001628280-23-036758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-036758","line_url":"/filing/0001628280-23-036758#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230645.0,"shares_display":"230,645","price_per_share":0.73,"price_display":"0.73","price_state":"stated","total_value":168370.85,"total_display":"168,370.85","total_whole":"168,371","shares_owned_after":80221.0,"shares_owned_after_display":"80,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-03","scope":"insider"},{"id":8088610,"accession":"0001628280-23-024228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-024228","line_url":"/filing/0001628280-23-024228#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2641.0,"shares_display":"2,641","price_per_share":1.89,"price_display":"1.89","price_state":"stated","total_value":4991.49,"total_display":"4,991.49","total_whole":"4,991","shares_owned_after":80221.0,"shares_owned_after_display":"80,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-07-05","scope":"insider"},{"id":7983178,"accession":"0001628280-23-023443","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-023443","line_url":"/filing/0001628280-23-023443#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5417.0,"shares_display":"5,417","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":10454.81,"total_display":"10,454.81","total_whole":"10,455","shares_owned_after":82862.0,"shares_owned_after_display":"82,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-26","scope":"insider"},{"id":8593397,"accession":"0001628280-23-022473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-022473","line_url":"/filing/0001628280-23-022473#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5417.0,"shares_display":"5,417","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":12025.74,"total_display":"12,025.74","total_whole":"12,026","shares_owned_after":88279.0,"shares_owned_after_display":"88,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-16","scope":"insider"},{"id":7951588,"accession":"0001628280-23-007722","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-007722","line_url":"/filing/0001628280-23-007722#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52500.0,"shares_display":"52,500","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":44100.0,"total_display":"44,100.00","total_whole":"44,100","shares_owned_after":93696.0,"shares_owned_after_display":"93,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-13","scope":"insider"},{"id":8268220,"accession":"0001628280-23-003757","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-003757","line_url":"/filing/0001628280-23-003757#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27721.0,"shares_display":"27,721","price_per_share":0.93,"price_display":"0.93","price_state":"stated","total_value":25780.53,"total_display":"25,780.53","total_whole":"25,781","shares_owned_after":146196.0,"shares_owned_after_display":"146,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider"},{"id":6870756,"accession":"0001628280-22-023323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-023323","line_url":"/filing/0001628280-22-023323#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10834.0,"shares_display":"10,834","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":173917.0,"shares_owned_after_display":"173,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-19","scope":"insider"},{"id":6311021,"accession":"0001628280-22-018400","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-018400","line_url":"/filing/0001628280-22-018400#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2641.0,"shares_display":"2,641","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":184751.0,"shares_owned_after_display":"184,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-30","filed_date":"2022-07-01","scope":"insider"},{"id":6733003,"accession":"0001628280-22-018047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-018047","line_url":"/filing/0001628280-22-018047#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5416.0,"shares_display":"5,416","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":187392.0,"shares_owned_after_display":"187,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-24","filed_date":"2022-06-27","scope":"insider"},{"id":6830662,"accession":"0001628280-22-017438","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-017438","line_url":"/filing/0001628280-22-017438#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5416.0,"shares_display":"5,416","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":192808.0,"shares_owned_after_display":"192,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-16","filed_date":"2022-06-17","scope":"insider"},{"id":6960004,"accession":"0001628280-22-002511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-002511","line_url":"/filing/0001628280-22-002511#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27721.0,"shares_display":"27,721","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":93224.0,"shares_owned_after_display":"93,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-14","scope":"insider"},{"id":5419293,"accession":"0001628280-21-017333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-017333","line_url":"/filing/0001628280-21-017333#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10832.0,"shares_display":"10,832","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":55243.2,"total_display":"55,243.20","total_whole":"55,243","shares_owned_after":120945.0,"shares_owned_after_display":"120,945","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":4243696,"accession":"0001628280-21-013299","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-013299","line_url":"/filing/0001628280-21-013299#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2641.0,"shares_display":"2,641","price_per_share":6.64,"price_display":"6.64","price_state":"stated","total_value":17536.24,"total_display":"17,536.24","total_whole":"17,536","shares_owned_after":131777.0,"shares_owned_after_display":"131,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-30","filed_date":"2021-07-01","scope":"insider"},{"id":4945933,"accession":"0001628280-21-012933","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-012933","line_url":"/filing/0001628280-21-012933#line-2","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5417.0,"shares_display":"5,417","price_per_share":7.01,"price_display":"7.01","price_state":"stated","total_value":37973.17,"total_display":"37,973.17","total_whole":"37,973","shares_owned_after":134418.0,"shares_owned_after_display":"134,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-24","filed_date":"2021-06-25","scope":"insider"},{"id":4279275,"accession":"0001628280-21-012477","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-012477","line_url":"/filing/0001628280-21-012477#line-2","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5417.0,"shares_display":"5,417","price_per_share":7.84,"price_display":"7.84","price_state":"stated","total_value":42469.28,"total_display":"42,469.28","total_whole":"42,469","shares_owned_after":123585.0,"shares_owned_after_display":"123,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-17","scope":"insider"},{"id":2765672,"accession":"0001628280-20-013832","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-013832","line_url":"/filing/0001628280-20-013832#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10834.0,"shares_display":"10,834","price_per_share":7.08,"price_display":"7.08","price_state":"stated","total_value":76704.72,"total_display":"76,704.72","total_whole":"76,705","shares_owned_after":29589.0,"shares_owned_after_display":"29,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-21","filed_date":"2020-09-22","scope":"insider"},{"id":3163257,"accession":"0001628280-20-010103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-20-010103","line_url":"/filing/0001628280-20-010103#line-2","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001738081","owner_name":"Mostafa Adam S.","owner_display_name":"Mostafa Adam S.","owner_url":"/insider/0001738081","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1725.0,"shares_display":"1,725","price_per_share":9.04,"price_display":"9.04","price_state":"stated","total_value":15594.0,"total_display":"15,594.00","total_whole":"15,594","shares_owned_after":8839.0,"shares_owned_after_display":"8,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-30","filed_date":"2020-07-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001501697","name":"X4 Pharmaceuticals, Inc","url":"/issuer/0001501697","role":"Officer (Chief Financial Officer)","n_filings":21,"first_seen":"2020-07-01","last_seen":"2025-01-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001738081","retrieved_at":"2026-08-26T19:28:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}